Exposure-response Analysis of Alemtuzumab in Pediatric Allogeneic HSCT for Nonmalignant Diseases: the ARTIC StudyFederica R. Achini-Gutzwiller,Marco W. Schilham,Erik G. J. von Asmuth,Anja M. Jansen-Hoogendijk, Cornelia M. van der Zijde,Maarten J. D. van Tol,Robbert G. M. Bredius,Tayfun Gungor,Arjan C. Lankester,Dirk Jan A. R. MoesBlood advances(2023)引用 2|浏览37暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要